OTCM
DKDRF
Market cap6.50bUSD
Sep 14, Last price
5.50USD
1D
4.76%
1Q
-3.27%
Name
Newmed Energy LP
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
NewMed Energy - Limited Partnership, headquartered in Herzliya, Israel, is an energy company primarily involved in the upstream oil and gas sector. Its operations encompass the exploration, development, extraction, and marketing of crude oil, natural gas, and condensate across Israel and Cyprus. The partnership possesses significant interests in several key energy projects. These include the substantial Leviathan project, spanning 500 km² off the coast of Haifa, and the Yam Tethys project, also covering 500 km² situated west of Ashkelon. In Cyprus, it holds a stake in Block 12, an area approximately 386 km² in size. Additionally, its Israeli portfolio features the New Ofek license (around 344 km²) and the New Yahel license (397.5 km²), alongside the Tanin and Karish leases, which together cover about 500 km² west of Nahariya. NewMed Energy serves a diverse clientele, including independent power producers and various industrial companies. The general partner overseeing its operations is NewMed Energy Management Ltd. Originally established in 1993, the entity was formerly known as Delek Drilling - Limited Partnership before adopting its current name in February 2022. It functions as a subsidiary of Delek Energy Systems Ltd.
Key people
Tal Levi
Finance Director · since 2013
Yaniv Friedman
Executive Vice President · since 2015
Yosef Gvura
Executive Vice President-Finance · since 2011
Zvi Karcz
Vice President-Exploration · since 2014
General Counsel · since 2017
Internal Auditor · since 2016
Nadav Perry
Manager of Communications & External Relations · since 2015
Director · since 2001
Director · since 2015
Amos Yaron
External Director · since 2015
Headquarters & legal address
19 Abba Eban Blvd.
Herzliya, TA 4672537
IL
Herzliya, TA 4672537
IL
Previous name
Delek Drilling - Limited Partnership
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||